Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2007
09/07/2007WO2007098557A1 Regulation of immune responses by modulation of the function of antigen presenting cells
09/07/2007WO2007098548A1 A molecule and chimeric molecules thereof
09/07/2007WO2007098547A1 A molecule and chimeric molecules thereof
09/07/2007WO2007098541A1 Tissue regeneration ii
09/07/2007WO2007084441A3 Novel fsh glycosylation variant d3n
09/07/2007WO2007084001A3 Means and methods for modulating stem cell mobilization
09/07/2007WO2007082909A3 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421
09/07/2007WO2007082483B1 Medicament for treatment of tumor and the use thereof
09/07/2007WO2007082482B1 Novel compound for treatment of tumor
09/07/2007WO2007078761A3 Method for prolonging activity of autodegradable enzymes and compositions thereof
09/07/2007WO2007078443A3 Methods of treating unwanted immune response with random copolymers
09/07/2007WO2007060486A3 Treatment of neurodegenerative disorders
09/07/2007WO2007059761A3 Medicament for treating problems relating to fertility and pregnancy, and auto-immune diseases, and for inducing an immunological tolerance in transplant patients, and method for producing said medicament
09/07/2007WO2007047803A3 Use of prolactin in the prophylactic treatment of cancer
09/07/2007WO2007039231A3 Method of producing a modified (poly)peptide
09/07/2007WO2007023243A3 Cleavage of antifolate compounds
09/07/2007WO2006130552A3 Methods of treating hepatitis c virus
09/07/2007WO2006117538A3 Assays for diagnosis of tuberculosis and uses thereof
09/07/2007WO2006116560A3 Surface active and interactive protein polymers and methods of making the same
09/07/2007WO2006079217A8 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis
09/07/2007WO2006020541A3 Methods for synthesizing polypeptides
09/07/2007WO2005011605A3 Combination therapies for multiple sclerosis
09/07/2007WO2004094455A8 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
09/07/2007CA2652677A1 Methods and compositions for the treatment of gastrointestinal disorders
09/07/2007CA2650113A1 Ankyrin-like motif-based peptides for the treatment of cancer
09/07/2007CA2644933A1 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
09/07/2007CA2644513A1 Preventing il-2 mediated inflammation in epithelial cells
09/07/2007CA2644461A1 G-csf liquid formulation
09/07/2007CA2644431A1 Pharmaceutical composition containing ghrp-6 capable of preventing and eliminating fibrosis and other forms of pathological deposit in tissue
09/07/2007CA2644426A1 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor
09/07/2007CA2644377A1 Master gene of arteriogenesis
09/07/2007CA2644058A1 Regulation of immune responses by modulation of the function of antigen presenting cells
09/07/2007CA2644046A1 Metabolic regulators and uses thereof
09/07/2007CA2643892A1 Antidepressant prodrugs
09/07/2007CA2643802A1 Methods for regulating neurotransmitter systems by inducing counteradaptations
09/07/2007CA2643723A1 Cathepsin propeptide and uses thereof
09/07/2007CA2643722A1 Use of the engrailed homeodomain protein as an anxiolytic
09/07/2007CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
09/07/2007CA2643282A1 Compositions and methods for effecting controlled posterior vitreous detachment
09/07/2007CA2643238A1 Improved antitumoral treatments
09/07/2007CA2643171A1 Collagenase for treating cellulite
09/07/2007CA2643111A1 Targeted delivery of pharmaceutical compounds
09/07/2007CA2643100A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
09/07/2007CA2642994A1 Immunogenic page-4 peptides and methods of use
09/07/2007CA2642984A1 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
09/07/2007CA2642943A1 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
09/07/2007CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
09/07/2007CA2642769A1 Biomarkers for amyotrophic lateral sclerosis and methods using the same
09/07/2007CA2642197A1 Compositions containing peptides with non-natural amino acids and methods of use
09/07/2007CA2641519A1 Compositions and methods for modulating hemostasis using variant forms of activated factor v
09/07/2007CA2641513A1 Methods of treating inflammatory and autoimmune diseases with natalizumab
09/07/2007CA2641160A1 Methods of treating inflammatory and autoimmune diseases with alpha-4 inhibitory compounds
09/07/2007CA2638943A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction
09/07/2007CA2638822A1 Adir related polymorphisms and applications thereof
09/07/2007CA2638800A1 Oxyntomodulin derivatives
09/07/2007CA2638733A1 Selective vpac2 receptor peptide agonists
09/07/2007CA2638038A1 Tissue adhesives and sealants and methods for their use
09/07/2007CA2637593A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them
09/07/2007CA2623413A1 Stem cell factor-like protein scfa1 and uses thereof
09/06/2007US20070208167 Compounds and methods for modulating activation of NF-kappaB
09/06/2007US20070208163 Method for treatment of protein precipitates
09/06/2007US20070208075 Pharmaceutical compositions
09/06/2007US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity
09/06/2007US20070207969 Treatment of cancers of lymphocytic cells with product R
09/06/2007US20070207968 Peptidomimetic Inhibitors Of Retroviral Proteases And Their Use As Antivirals
09/06/2007US20070207967 Peptide Inhibitors of Matrix Metalloproteinase Activity
09/06/2007US20070207966 mixing a small interfering RNA with a conjugate comprising a cholesterol residue covalently bonded to oligoarginine through a formate residue linker, thereby forming the complex; carrier for delivery of an siRNA targeted to vascular endothelial growth factor for the treatment for cancer
09/06/2007US20070207965 Method for the treatment of skin fibrosis and suitable compositions for such treatment
09/06/2007US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia
09/06/2007US20070207963 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
09/06/2007US20070207962 Intravenous blood-replacement solutions
09/06/2007US20070207961 TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
09/06/2007US20070207960 Mutants of the factor VII epidermal growth factor domain
09/06/2007US20070207959 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
09/06/2007US20070207958 Method of treatment of diabetes and/or obesity with reduced nausea side effect
09/06/2007US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis
09/06/2007US20070207956 Stabilised solid compositions of factor VII polypeptides
09/06/2007US20070207955 Novel polypeptide and process for producing the same, and collagenase inhibitor
09/06/2007US20070207954 molecular weight is 15863.79 Da; has higher drug potentiation than from the mycelium of G. lucidum
09/06/2007US20070207953 Host Defense Factor X (HDFX)
09/06/2007US20070207952 Long Acting Biologically Active Conjugates
09/06/2007US20070207951 Treatment with cyclosporin a
09/06/2007US20070207950 Methods and compositions for regulating HDAC6 activity
09/06/2007US20070207949 Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
09/06/2007US20070207948 Convergent Synthesis for Kahalalide Compounds
09/06/2007US20070207947 Stabilized Peptides
09/06/2007US20070207946 Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
09/06/2007US20070207944 Blood Pressure Lowering Oligopeptides
09/06/2007US20070207943 Interleukins-21 and 22
09/06/2007US20070207930 Rhamnolipid compositions and related methods of use
09/06/2007US20070207523 Mammalian t-type calcium channels
09/06/2007US20070207507 Selective identification of vulnerable plaques in coronary and other arteries using non-invasive imaging methods; myeloperoxidase; acute coronary syndromes
09/06/2007US20070207497 Receptor ligands and methods of modulating receptors
09/06/2007US20070207475 Method for producing polymers having a preselected activity
09/06/2007US20070207462 Preventive/Remedy for Respiratory Diseases
09/06/2007US20070207231 Composition and use of phyto-percolate for treatment of disease
09/06/2007US20070207218 Combinations of vanadium with antidiabetics for glucose metabolism disorders
09/06/2007US20070207210 Protein Microspheres Retaining Pharmacokinetic and Pharmacodynamic Properties
09/06/2007US20070207209 Trophic factor combinations for nervous system treatment
09/06/2007US20070207185 Compositions and methods for treating bone